Is Immune Checkpoint Inhibition Part of Standard Therapy for Stage III Non-Small Cell Lung Cancer?

被引：0
|
作者：
Patel, Jyoti D. [1 ]
Chmura, Steven J. [2 ]
机构：
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Radiat Oncol, Chicago, IL 60637 USA
来源：
CANCER | 2018年 / 124卷 / 14期
关键词：
RANDOMIZED PHASE-III; CONSOLIDATION; RADIOTHERAPY; CONCURRENT; TRIAL; PEMBROLIZUMAB; CISPLATIN; RADIATION; DOCETAXEL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2878 / 2880
页数：3
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    [J]. CANCER, 2018, 124 (02) : 248 - 261
  • [42] Management of stage III non-small cell lung cancer
    Tabchi, Samer
    Kassouf, Elie
    El Rassy, Elie
    Kourie, Hampig Raphael
    Martin, Jocelyne
    Campeau, Marie-Pierre
    Tehfe, Mustapha
    Blais, Normand
    [J]. SEMINARS IN ONCOLOGY, 2017, 44 (03) : 163 - 177
  • [43] Chemoradiation for stage III non-small cell lung cancer
    Ramella, Sara
    Fiore, Michele
    Iurato, Aurelia
    Trodella, Luca E.
    Trodella, Lucio
    D'Angelillo, Rolando M.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
  • [44] Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
    Gao, Yinjie
    Stein, Michelle M.
    Kase, Matthew
    Cummings, Amy L.
    Bharanikumar, Ramit
    Lau, Denise
    Garon, Edward B.
    Patel, Sandip P.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 339 - 350
  • [45] Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
    Yinjie Gao
    Michelle M. Stein
    Matthew Kase
    Amy L. Cummings
    Ramit Bharanikumar
    Denise Lau
    Edward B. Garon
    Sandip P. Patel
    [J]. Cancer Immunology, Immunotherapy, 2023, 72 : 339 - 350
  • [46] The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study
    Hsu, Jason C.
    Nguyen, Phung-Anh
    Chen, Yen-Tzu
    Yang, Szu-Chun
    Lin, Chien-Chung
    Yang, Yi-Hsin
    Lin, Yu-Chao
    Hsia, Te-Chun
    Hsieh, Hsing-Chun
    Wu, Jia-Syuan
    Chang, Chi-Pei
    Feng, Yin-Hsun
    Lin, Peng-Chan
    Hsu, Ping-Chih
    Tzeng, Huey-En
    Chien, Shu-Chen
    Chang, Wei-Chiao
    Chang, Chih-Cheng
    Yang, Hsuan-Chia
    Lee, Chueh Ming
    Lu, Christine Y.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
    Corke, Lucy K.
    Li, Janice J. N.
    Leighl, Natasha B.
    Eng, Lawson
    [J]. CURRENT ONCOLOGY, 2022, 29 (09) : 6260 - 6276
  • [48] Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
    Travert, Camille
    Tomasini, Pascale
    Barlesi, Fabrice
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 401 - 405
  • [49] Acute hyponatremia from immune checkpoint inhibitor therapy for non-small cell lung cancer
    Desikan, Sai Prasad
    Varghese, Ron
    Kamoga, Roy
    Desikan, Raman
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1139) : 570 - 571
  • [50] Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases
    Fan-jie Qu
    Yi Zhou
    Shuang Wu
    [J]. British Journal of Cancer, 2024, 130 : 165 - 175
12345